On the recordFebruary 8, 2012
In the face of these challenges, the FDA and the generic pharmaceutical industry have come together with other stakeholders to negotiate a historic 5-year agreement.
Source
congress.govEditor's note · Context
Murphy discusses a new agreement aimed at improving drug approval processes.
Share
More from Tim Murphy
Sep 12, 2017
I want to restate the problems that exist at SAMHSA. The General Accounting Office, during the multiyear investigation of the subcommittee which I chair, the Oversight and Investigations of the Committee on Energy and Commerce, came back…
Jul 17, 2017
I know that all of us are dedicated to ensuring that the 340B program achieves its critical mission of helping providers serve the indigent.
Sep 5, 2017
The loss and destruction of Hurricane Harvey makes today's hearing even more important.
Sep 12, 2017
Reclaiming my time, knowing that when my friend says something, I consider that a bond. Mr. Chairman, I yield back the balance of my time, and I withdraw my amendment. The Acting CHAIR. The amendment is withdrawn. Amendment No. 179 Offered…
Other voices in this conversation
